Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2011
Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patientsJon Amund Kyte, Gustav Gaudernack, Svein Dueland, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccinationJon Amund Kyte, Sissel Trachsel, Bente Risberg, et al.
International Journal of Molecular Sciences|January 11, 2024
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and SpacersYixin Jin, Claire Dunn, Irene Persiconi, et al.
International Journal of Molecular Sciences|September 28, 2024
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586Yixin Jin, Claire Dunn, Irene Persiconi, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2006
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cellsJon Amund Kyte, Gunnar Kvalheim, Kari Lislerud, et al.
Biomedicines|February 25, 2023
Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell TherapyCarole Beck, Nicholas Paul Casey, Irene Persiconi, et al.
Oncoimmunology|December 20, 2024
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survivalRagnhild Reehorst Lereim, Claire Dunn, Elin Aamdal, et al.
Ecancermedicalscience|December 21, 2016
Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisationLinda Cairns, Sandrine Aspeslagh, Andrea Anichini, et al.
Molecular Oncology|August 25, 2025
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapyAndreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trialPaal Fr Brunsvig, Jon Amund Kyte, Christian Kersten, et al.
Pageof 5